NSIP
Showing 1 - 23 of 23
stratification for IPF and COPD
Not yet recruiting
- Lung; Disease, Interstitial, With Fibrosis
- +2 more
- Lung auscultation
- +3 more
-
Sion, Wallis, SwitzerlandCentre Hospitalier du Valais Romand
Sep 1, 2022
Idiopathic Interstitial Pneumonias: a Prospective Study
Recruiting
- Idiopathic Interstitial Pneumonia
- +2 more
- Microarray analysis
-
London, Ontario, CanadaLondon Health Science Centre
Oct 15, 2021
Genentech Validation Tool for Pulmonary Fibrosis
Recruiting
- Interstitial Lung Disease
-
New York, New YorkColumbia University Irving Medical Center
Nov 4, 2022
The Clinical Course of Interstitial Pneumonia With Autoimmune
Recruiting
- Interstitial Pneumonia
-
London, Ontario, CanadaLondon Health Science Centre
Apr 5, 2022
Interstitial Lung Disease, Chronic Thromboembolic Pulmonary Hypertension, Acute Pulmonary Embolism Trial in Durham
Not yet recruiting
- Interstitial Lung Disease
- +4 more
- Hyperpolarized Xe129
- Oxygen Administration
-
Durham, North CarolinaDuke University Medical Center
Sep 8, 2023
Creation ofBiospecimen Repository From Interstitial Lung
Recruiting
- Interstitial Lung Disease
- ILD
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jan 11, 2022
Monitoring and Evaluation Study of Project ECHO for ILD
Enrolling by invitation
- Interstitial Lung Diseases
-
Boston, MassachusettsPulmonary Care and Research Collaborative, Ltd.
Jul 7, 2022
Idiopathic Pulmonary Fibrosis, Idiopathic Interstitial Pneumonia, Interstitial Lung Diseases Trial in Worldwide (patient
Recruiting
- Idiopathic Pulmonary Fibrosis
- +3 more
- patient registry (observation and biomaterial sampling)
-
Vienna, Austria
- +6 more
Nov 2, 2021
Interstitial Lung Disease Trial in Rochester (Amitriptyline 25 MG, Amitriptyline 50 MG, Duloxetine 30 MG)
Recruiting
- Interstitial Lung Disease
- Amitriptyline 25 MG
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 4, 2022
Connective Tissue Disease-associated Interstitial Lung Disease, Interstitial Lung Disease, Connective Tissue Diseases Trial in
Unknown status
- Connective Tissue Disease-associated Interstitial Lung Disease
- +2 more
- Telemonitoring
-
Łódź, Lodz Province, PolandDepartment of Pneumology and Allergy, Medical University of Lodz
Jun 9, 2020
Evaluation of Connective Tissue Disease Incidence During
Unknown status
- Idiopathic Interstitial Pneumonia
- Follow-up
-
Lille, France
- +1 more
Nov 25, 2019
Fibrosis in the Lung Clinical Endpoints Study
Completed
- Idiopathic Pulmonary Fibrosis
- Idiopathic Non-specific Interstitial Pneumonitis
-
London, United KingdomRoyal Brompton Hospital
Mar 25, 2019
(IPAF) -Multicenter Prospective Study
Not yet recruiting
- Interstitial Lung Disease
- +3 more
- Bronchoalveolar lavage and taking bronchial mucosa samples
- +3 more
-
Messina, Province Of Messina, Italy
- +6 more
Mar 10, 2019
Fibrosis In the Lung Endpoints (PROFILE - Central England)
Completed
- Idiopathic Pulmonary Fibrosis
-
Nottingham, United KingdomNottingham University Hospitals NHS Trust
Oct 10, 2018
Hypersensitivity Pneumonitis, Airway Disease Small Trial in São Paulo (Salbutamol)
Completed
- Hypersensitivity Pneumonitis
- Airway Disease Small
-
São Paulo, BrazilOlívia Meira Dias
May 1, 2018
Interstitial Lung Diseases, Rheumatoid Arthritis, Asthma Trial in Odense (Fibrocyte measurement and lung function test.)
Completed
- Interstitial Lung Diseases
- +2 more
- Fibrocyte measurement and lung function test.
-
Odense, DenmarkOdense University Hospital
Apr 20, 2017
Lung Diffusing Capacity for Nitric Oxide asMarker of Fibrotic
Completed
- Usual Interstitial Pneumonia
- Nonspecific Interstitial Pneumonia
- (no location specified)
Nov 2, 2015
Idiopathic Pulmonary Fibrosis Trial in Bologna (68Ga-DOTA-NOC PET/CT)
Terminated
- Idiopathic Pulmonary Fibrosis
- 68Ga-DOTA-NOC PET/CT
-
Bologna, ItalyNuclear Medicine, Azienda Ospedaliero Universitaria di Bologna,
Jan 26, 2015
Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF)
Unknown status
- Interstitial Lung Diseases
- No intervention
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital, Tongji University
Jul 24, 2015
Undergoing ERCP for Diagnostic or Therapeutic Purposes Trial in Seongnam (Dexmedetomidine, normal saline)
Completed
- Undergoing ERCP for Diagnostic or Therapeutic Purposes
- Dexmedetomidine
- normal saline
-
Seongnam, Gyeonggi-do, Korea, Republic ofDivision of Gastroenterology, Department of Internal Medicine, S
Jul 13, 2013
Rheumatoid Arthritis, Interstitial Pneumonia Trial in Boston, Rochester (Rituximab)
Completed
- Rheumatoid Arthritis
- Interstitial Pneumonia
-
Boston, Massachusetts
- +1 more
Sep 25, 2012
Fibrotic Interstitial Lung Disease and Cardiac Disease /
Unknown status
- Idiopathic Pulmonary Fibrosis
- Interstitial Pneumonia
-
London, United KingdomSt George's Hospital
Jun 30, 2010
Idiopathic Pulmonary Fibrosis Trial in Los Angeles (minocycline)
Unknown status
- Idiopathic Pulmonary Fibrosis
-
Los Angeles, CaliforniaUCLA Pulmonary Outpatient Clinic
Sep 7, 2006